All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Iron chelation in the treatment of neurodegenerative diseases

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F16%3A10328117" target="_blank" >RIV/00216208:11110/16:10328117 - isvavai.cz</a>

  • Alternative codes found

    RIV/00064165:_____/16:10328117

  • Result on the web

    <a href="http://dx.doi.org/10.1016/j.jtemb.2016.03.010" target="_blank" >http://dx.doi.org/10.1016/j.jtemb.2016.03.010</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1016/j.jtemb.2016.03.010" target="_blank" >10.1016/j.jtemb.2016.03.010</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Iron chelation in the treatment of neurodegenerative diseases

  • Original language description

    Disturbance of cerebral iron regulation is almost universal in neurodegenerative disorders. There is a growing body of evidence that increased iron deposits may contribute to degenerative changes. Thus, the effect of iron chelation therapy has been investigated in many neurological disorders including rare genetic syndromes with neurodegeneration with brain iron accumulation as well as common sporadic disorders such as Parkinson's disease, Alzheimer's disease, and multiple sclerosis. This review summarizes recent advances in understanding the role of iron in the etiology of neurodegeneration. Outcomes of studies investigating the effect of iron chelation therapy in neurodegenerative disorders are systematically presented in tables. Iron chelators, particularly the blood brain barrier-crossing compound deferiprone, are capable of decreasing cerebral iron in areas with abnormally high concentrations as documented by MRI. Yet, currently, there is no compelling evidence of the clinical effect of iron removal therapy on any neurological disorder. However, several studies indicate that it may prevent or slow down disease progression of several disorders such as aceruloplasminemia, pantothenate kinase-associated neurodegeneration or Parkinson's disease.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FH - Neurology, neuro-surgery, nuero-sciences

  • OECD FORD branch

Result continuities

  • Project

    Result was created during the realization of more than one project. More information in the Projects tab.

  • Continuities

    P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Others

  • Publication year

    2016

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Journal of Trace Elements in Medicine and Biology

  • ISSN

    0946-672X

  • e-ISSN

  • Volume of the periodical

    38

  • Issue of the periodical within the volume

    December

  • Country of publishing house

    DE - GERMANY

  • Number of pages

    12

  • Pages from-to

    81-92

  • UT code for WoS article

    000385473600010

  • EID of the result in the Scopus database

    2-s2.0-84992036208